Biomaterials Market is projected to reach USD 47.5 billion by 2025 from USD 35.5 billion in 2020, at a CAGR of 6.0% during the forecast period. They are materials that are designed to interact with biological systems, such as tissue, cells, and organs, for a wide variety of medical and healthcare applications. They are used in a variety of applications, including implants, prosthetics, wound dressings, and drug delivery systems.
The biomaterials market is driven by factors such as increasing investments in research and development of biomaterials, growing demand for medical devices, and increasing demand for tissue engineering. Additionally, the rising prevalence of chronic diseases, an aging population, and the increasing number of surgeries are expected to propel the market growth over the forecast period.
The global biomaterials market is expected to experience significant growth over the forecast period, primarily due to increasing investments in RD, growing demand for medical devices, and rising prevalence of chronic diseases. Additionally, the increasing number of surgeries, an aging population, and the growing demand for tissue engineering are expected to further boost the market growth in the upcoming years.
Get a sample of the report: https://www.globenewswire.com/en/news-release/2022/06/16/2463954/0/en/Biomaterials-Market-worth-47-5-billion-by-2025-Report-by-MarketsandMarkets.html
Top Lading Players: BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Corbion (Netherlands), Royal DSM (Netherlands), Evonik Industries (Germany), Carpenter Technology Corporation (US), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), CoorsTek Inc. (US), CeramTec (Germany), and GELITA AG (Germany)
Some Key Highlights from the Report:
- The global biomaterials market is expected to grow at a CAGR of 6.0% from 2020 to 2025 to reach USD 47.5 billion by 2026.
- The increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and orthopedic disorders, is expected to drive the growth of the biomaterials market.
- The increasing demand for minimally invasive procedures and use of biomaterials for reconstructive surgeries are expected to drive the growth of the market.
- The growing demand for medical implants, such as dental implants, joint replacement, and cardiovascular implants, is expected to drive the demand for biomaterials.
- The increasing investments in research and development (RD) activities to develop advanced biomaterials is expected to drive the growth of the biomaterials market.
- The emergence of 3D-printed biomaterials and nanomaterials is expected to provide growth opportunities for the biomaterials market.
- However, the high cost of biomaterials and their associated manufacturing processes is expected to restrain the growth of the market.
Segments covered in the report:
By Type
- Metallic Biomaterials
- Polymeric Biomaterials
- Ceramics
- Natural Biomaterials
By Application
- Cardiovascular
- Orthopedic
- Ophthalmology
- Dental
- Plastic Surgery
- Wound Healing
- Tissue Engineering
- Neurological/Central Nervous System Applications
- Other Applications
Ask for Customize Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=393
Regional Outlook:
- North America (U.S.A., Canada, Mexico)
- Europe (Italy, U.K., Germany, France, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
- Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Questions Addressed in the Report:
- What are the dominating factors that are influencing the growth of the industry?
- In the forecast period, which market segment is expected to rise the most?
- What are the risks and challenges that the industry is facing?
- In the coming years, which area is projected to dominate the market?
- Who are the major players in the market?
- What kind of strategic business plans have they made?
Make an inquiry to Buy this Report @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=235810711
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
